GlassScriptPhysician profile
Alyssa Mary Darrah
NPI 1114423563
$1,639.73
in general payments reported to CMS, 2019-2025
17 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $105 · 2023: $227 · 2024: $653 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,534.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $432.10 | 2022-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $353.69 | 2022-2025 | Xiidra, Miebo, Lotemax Sm |
| Tarsus Pharmaceuticals, INC. | $167.37 | 2024-2025 | Xdemvy |
| Abbvie INC. | $142.18 | 2022-2025 | Vuity, Alphagan P, Lumigan |
| Sight Sciences, INC. | $115.65 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Oyster Point Pharma, INC. | $71.39 | 2022-2023 | Tyrvaya |
| Harrow Eye, LLC | $53.78 | 2024-2025 | Vevye |
| Glaukos Corporation | $51.30 | 2024-2025 | Istent Infinite, Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Rayner Intraocular Lenses Limited | $45.84 | 2022-2024 | Omidria, Rayone Emv, Rayone Aspheric |
| Sun Pharmaceutical Industries INC. | $40.73 | 2023-2025 | Cequa |
| Dompe US, INC. | $28.62 | 2025 | Oxervate |
| New World Medical,INC. | $28.28 | 2025 | Clearpath, Kahook Dual Blade, Via360 |
| Merz Pharmaceuticals, LLC | $27.15 | 2024 | Xeomin |
| Thea Pharma INC. | $24.13 | 2025 | Iyuzeh |
| Amgen INC. | $22.85 | 2024 | Tepezza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $20.81 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $13.86 | 2025 | Catalys System, Tecnis Iol, Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Darrah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.